Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2009

View Archived Issues

Mitomycin C may prevent bladder tumor formation in upper tract transitional cell carcinoma patients

Pfizer introduces four novel MMP-13 inhibitors as candidates for osteoarthritis treatment

IMPACT2 shows relief of hereditary angioedema attacks with C1-INH

Novel P-glycoprotein inhibitor is developed as an oral absorption enhancing agent

Novel compounds for the treatment of hepatitis C discovered by Bristol-Myers Squibb

Pfizer presents novel cholesteryl ester transfer protein inhibitors

Regeneron initiates phase III gout program with Arcalyst

Phase III ASA-404 trial in lung cancer extended to Japan

Advancell collaborates with Nobera to develop hand-foot syndrome treatment

Novel neutrophil elastase inhibitor shows efficacy in rat lung injury model

Abeille licenses AB-1001 to Prostrakan for North America and Europe

Cyclopamine analogues developed for cancer treatment

Emerflu pandemic influenza vaccine approved in Australia

Exenatide data analysis shows no increased risk of cardiovascular events

Trubion initiates phase I SBI-087 study in systemic lupus erythematosus

Roche completes tender offer for Genentech

RegeneRx presents phase II RGN-137 results in venous stasis

Neurotech reports phase II NT-501 results in dry AMD

Neurocrine reports top-line results from phase II elagolix trial in endometriosis

Novel histone deacetylase inhibitors claimed by Syndax Pharmaceuticals

Molecular Insight reports detailed phase II data for Zemiva

Recent Roche patent claims novel Raf kinase B and C inhibitors as antiproliferative agents

GlycoMimetics completes two phase I studies for GMI-1070

Novel monoamine reuptake inhibitors emerge from GlaxoSmithKline R&D

Interim results from phase II EC-145 trial reported by Endocyte

Acadia and Meiji Seika enter collaboration for procognitive drugs for schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...